Death

·MeSH: Maternal Death

21 drugs in development·16 companies·3 clinical trials

Drug Pipeline by Phase

Approved(21)

Drug	Company
candesartan cilexetil	Aptinyx Inc. (APTX)
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)
Jardiance	ELI LILLY & Co (LLY)
Jardiance®	ELI LILLY & Co (LLY)
methadone	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
morphine	Impax Laboratories, LLC (IPXL)
morphine	SUNSET ISLAND GROUP (SUN)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
oxycodone	SUNSET ISLAND GROUP (SUN)
oxycodone	Nascent Biotech Inc. (NBIO)
ozempic	Novo Nordisk A/S (NVO)
paxlovid	PFIZER INC (PFE)
pravastatin	Aptinyx Inc. (APTX)
ticagrelor	Mylan II B.V. (MYL)
ticagrelor	Amneal Pharmaceuticals, Inc. (AMRX)
ticagrelor	DR REDDYS LABORATORIES LTD (RDY)
tirofiban	NEXUS BIOPHARMA INC (NEXS)
tramadol	Mylan II B.V. (MYL)
tramadol	SUNSET ISLAND GROUP (SUN)
tramadol	Prestige Consumer Healthcare Inc. (PBH)
Verquvo	Merck & Co., Inc. (MRK)

BioSniper tracks 21 drugs in development for Death across 16 companies.

There are 3 clinical trials targeting Death tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.